PATH
Menu

The study was undertaken to evaluate the acceptability and ease of use of the Uniject prefilled, single-use injection device by midwives at primary and secondary level facilities, the effectiveness of active management of the third stage of labor (AMTSL) in reducing rates of post partum hemorrhage (PPH) and the need for hemorrhage treatments, the cost-effectiveness of routine delivery of AMTSL, and the relative costs of using oxytocin in ampoules or in Uniject. The study was conducted in six districts of Thanh Hoa province from June to December 2004.

Corporate author(s): PATH; Vietnam MOH Reproductive Health Department

Publication date: 2003

Available materials

English

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Region: Asia

See also:

Health technologiesSafe injection

Maternal and child healthSafe birth and newborn care

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA